Melatonin synthesis impairment as a new deleterious outcome of diabetes-derived hyperglycemia

Journal of Pineal Research

Volumn 57, Issue 1, 2014, Pages 67-79

  Amaral, Fernanda G ^a   Turati, Ariane O ^a   Barone, Mark ^a   Scialfa, Julieta H ^a   Do Carmo Buonfiglio, Daniella ^a   Peres, Rafael ^a   Peliciari Garcia, Rodrigo A ^a   Afeche, Solange C ^b   Lima, Larissa ^a   Scavone, Cristoforo ^a   Bordin, Silvana ^a   Reiter, Russel J ^c   Menna Barreto, Luiz ^a   Cipolla Neto, José ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

arylalkylamine N acetyltransferase; diabetes; hyperglycemia; K ATPase; melatonin; microdialysis; Na; pineal

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; GLUCOSE; MELATONIN; 6-SULFATOXYMELATONIN; ARALKYLAMINE ACETYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; DIABETES MELLITUS; ENERGY METABOLISM; HOMEOSTASIS; HORMONE SYNTHESIS; HUMAN; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICRODIALYSIS; NONHUMAN; PINEAL BODY; RAT; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ANALOGS AND DERIVATIVES; ANIMAL; CELL SURVIVAL; COMPLICATION; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; WISTAR RAT;

ANIMALS; ARYLALKYLAMINE N-ACETYLTRANSFERASE; CELL SURVIVAL; DIABETES MELLITUS, EXPERIMENTAL; HUMANS; HYPERGLYCEMIA; MALE; MELATONIN; MICRODIALYSIS; PINEAL GLAND; RATS; RATS, WISTAR;

EID: 84904469447     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12144     Document Type: Article

References (54)

1. Erren TC, Reiter RJ,. Revisiting chronodisruption: when the physiological nexus between internal and external times splits in humans. Naturwissenschaften 2013; 100: 291-298.
2. Green CB, Takahashi JS, Bass J,. The meter of metabolism. Cell 2008; 134: 728-742.
3. Korkmaz A, Topal T, Tan DX, et al. Role of melatonin in metabolic regulation. Rev Endocr Metab Disord 2009; 10: 261-270.
4. Cipolla-Neto J, Amaral FG, Afeche SC, et al. Melatonin, energy metabolism and obesity: a review. J Pineal Res 2014; 56: 371-381.
5. Klein DC, Ganguly S, Coon S, et al. 14-3-3 Proteins and photoneuroendocrine transduction: role in controlling the daily rhythm in melatonin. Biochem Soc Trans 2002; 30: 365-373.
6. Garcia RA, Afeche SC, Scialfa JH, et al. Insulin modulates norepinephrine-mediated melatonin synthesis in cultured rat pineal gland. Life Sci 2008; 82: 108-114.
7. Picinato MC, Haber EP, Carpinelli AR, et al. Daily rhythm of glucose-induced insulin secretion by isolated islets from intact and pinealectomized rat. J Pineal Res 2002; 33: 172-177.
8. Anhe GF, Caperuto LC, Pereira-Da-silva M, et al. In vivo activation of insulin receptor tyrosine kinase by melatonin in the rat hypothalamus. J Neurochem 2004; 90: 559-566.
9. Nogueira TC, Lellis-Santos C, Jesus DS, et al. Absence of melatonin induces night-time hepatic insulin resistance and increased gluconeogenesis due to stimulation of nocturnal unfolded protein response. Endocrinology 2011; 152: 1253-1263.
10. Alonso-Vale MI, Andreotti S, Peres SB, et al. Melatonin enhances leptin expression by rat adipocytes in the presence of insulin. Am J Physiol Endocrinol Metab 2005; 288: E805-E812.
11. Hardeland R,. Melatonin and the theories of aging: a critical appraisal of melatonin's role in antiaging mechanisms. J Pineal Res 2013; 55: 325-356.
12. Lima FB, Machado UF, Bartol I, et al. Pinealectomy causes glucose intolerance and decreases adipose cell responsiveness to insulin in rats. Am J Physiol 1998; 275: E934-E941.
13. Reiter RJ, Richardson BA, Johnson LY, et al. Pineal melatonin rhythm: reduction in aging Syrian hamsters. Science 1980; 210: 1372-1373.
14. Mendes C, Lopes AM, Do Amaral FG, et al. Adaptations of the aging animal to exercise: role of daily supplementation with melatonin. J Pineal Res 2013; 55: 229-239.
15. Zanuto R, Siqueira-Filho MA, Caperuto LC, et al. Melatonin improves insulin sensitivity independently of weight loss in old obese rats. J Pineal Res 2013; 55: 156-165.
16. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C, et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2009; 41: 89-94.
17. Prokopenko I, Langenberg C, Florez JC, et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet 2009; 41: 77-81.
18. Montilla PL, Vargas JF, Tunez IF, et al. Oxidative stress in diabetic rats induced by streptozotocin: protective effects of melatonin. J Pineal Res 1998; 25: 94-100.
19. Nishida S, Segawa T, Murai I, et al. Long-term melatonin administration reduces hyperinsulinemia and improves the altered fatty-acid compositions in type 2 diabetic rats via the restoration of Delta-5 desaturase activity. J Pineal Res 2002; 32: 26-33.
20. Champney TH, Holtorf AP, Craft CM, et al. Hormonal modulation of pineal melatonin synthesis in rats and Syrian hamsters: effects of streptozotocin- induced diabetes and insulin injections. Comp Biochem Physiol A Comp Physiol 1986; 83: 391-395.
21. Pang SF, Tang F, Tang PL,. Alloxan-induced diabetes and the pineal gland: differential effects on the levels of pineal N-acetylserotonin, pineal melatonin, and serum melatonin. J Pineal Res 1985; 2: 79-85.
22. Peschke E, Frese T, Chankiewitz E, et al. Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J Pineal Res 2006; 40: 135-143.
23. Tutuncu NB, Batur MK, Yildirir A, et al. Melatonin levels decrease in type 2 diabetic patients with cardiac autonomic neuropathy. J Pineal Res 2005; 39: 43-49.
24. Do Carmo Buonfiglio D, Peliciari-Garcia RA, Do Amaral FG, et al. Early-stage retinal melatonin synthesis impairment in streptozotocin-induced diabetic wistar rats. Invest Ophthalmol Vis Sci 2011; 52: 7416-7422.
25. Peschke E, Wolgast S, Bazwinsky I, et al. Increased melatonin synthesis in pineal glands of rats in streptozotocin induced type 1 diabetes. J Pineal Res 2008; 45: 439-448.
26. Peschke E, Hofmann K, Bahr I, et al. The insulin-melatonin antagonism: studies in the LEW.1AR1-iddm rat (an animal model of human type 1 diabetes mellitus). Diabetologia 2011; 54: 1831-1840.
27. Peres R, Do Amaral FG, Madrigrano TC, et al. Ethanol consumption and pineal melatonin daily profile in rats. Addict Biol 2011; 16: 580-590.
28. Deguchi T, Axelrod J,. Sensitive assay for serotonin N-acetyltransferase activity in rat pineal. Anal Biochem 1972; 50: 174-179.
29. Ribelayga C, Pevet P, Simonneaux V,. Adrenergic and peptidergic regulations of hydroxyindole-O-methyltransferase activity in rat pineal gland. Brain Res 1997; 777: 247-250.
30. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034.
31. Bradford MM,. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
32. Kawamoto EM, Lima LS, Munhoz CD, et al. Influence of N-methyl- d -aspartate receptors on ouabain activation of nuclear factor-kappaB in the rat hippocampus. J Neurosci Res 2012; 90: 213-228.
33. Klein DC, Buda MJ, Kapoor CL, et al. Pineal serotonin N-acetyltransferase activity: abrupt decrease in adenosine 3′,5′-monophosphate may be signal for "turnoff". Science 1978; 199: 309-311.
34. Cena V, Gonzalez-Garcia C, Svoboda P, et al. Developmental study of ouabain inhibition of adrenergic induction of rat pineal serotonin N-acetyltransferase (EC 2.3.1.87). J Biol Chem 1987; 262: 14467-14471.
35. Shi Q, Zeng J, Dong Y, et al. Concurrent impairment of (Na++K+)-ATPase activity in multi-organ of type-1 diabetic NOD mice. J Diabetes Complications 2013; 27: 29-33.
36. Hocht C, Opezzo JA, Taira CA,. Applicability of reverse microdialysis in pharmacological and toxicological studies. J Pharmacol Toxicol Methods 2007; 55: 3-15.
37. Halberg F,. Quo vadis basic and clinical chronobiology: promise for health maintenance. Am J Anat 1983; 168: 543-594.
38. Devries JH, Snoek FJ, Heine RJ,. Persistent poor glycaemic control in adult Type 1 diabetes. A closer look at the problem. Diabet Med 2004; 21: 1263-1268.
39. Arendt J,. Melatonin. Clin Endocrinol (Oxf) 1988; 29: 205-229.
40. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37 (Suppl. 1): S81-S90.
41. Tsai MH, Wei IH, Jiang-Shieh YF, et al. Expression of protein gene product 9.5, tyrosine hydroxylase and serotonin in the pineal gland of rats with streptozotocin-induced diabetes. Neurosci Res 2008; 60: 233-243.
42. Gallicchio MA, Bach LA,. Advanced glycation end products inhibit Na+ K+ ATPase in proximal tubule epithelial cells: role of cytosolic phospholipase A2alpha and phosphatidylinositol 4-phosphate 5-kinase gamma. Biochim Biophys Acta 2010; 1803: 919-930.
43. Kade IJ, Nogueira CW, Rocha JB,. Diphenyl diselenide and streptozotocin did not alter cerebral glutamatergic and cholinergic systems but modulate antioxidant status and sodium pump in diabetic rats. Brain Res 2009; 1284: 202-211.
44. Torlinska K, Grochowalska A, Kupsz J, et al. In vivo and in vitro effects of hyperglycemia on Na+ -K+, Ca+2, Mg+2-dependent ATPases activity in brain synaptosomes of aging rats. J Physiol Pharmacol 2006; 57 (Suppl. 7): 145-158.
45. Niedowicz DM, Daleke DL,. The role of oxidative stress in diabetic complications. Cell Biochem Biophys 2005; 43: 289-330.
46. Allegra M, Reiter RJ, Tan DX, et al. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003; 34: 1-10.
47. Galano A, Tan DX, Reiter RJ,. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51: 1-16.
48. Galano A, Tan DX, Reiter RJ,. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013; 54: 245-257.
49. Tan DX, Manchester LC, Terron MP, et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007; 42: 28-42.
50. Bass J, Takahashi JS,. Circadian integration of metabolism and energetics. Science 2010; 330: 1349-1354.
51. McMullan CJ, Schernhammer ES, Rimm EB, et al. Melatonin secretion and the incidence of type 2 diabetes. JAMA 2013; 309: 1388-1396.
52. Barone MT, Menna-Barreto L,. Diabetes and sleep: a complex cause-and-effect relationship. Diabetes Res Clin Pract 2011; 91: 129-137.
53. Garfinkel D, Zorin M, Wainstein J, et al. Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study. Diabetes Metab Syndr Obes 2011; 4: 307-313.
54. Kozirog M, Poliwczak AR, Duchnowicz P, et al. Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. J Pineal Res 2011; 50: 261-266.